识别组样本量与图像分辨率对代谢型阿尔茨海默病相关模式诊断性能的影响
从阿尔茨海默病神经影像学倡议数据库选取240例[18F]氟脱氧葡萄糖正电子发射断层扫描图像(120例阿尔茨海默病/120例认知正常),用200例(100/100)经缩放子分布模型/主成分分析识别750个阿尔茨海默病相关模式版本,其余20例阿尔茨海默病/20例认知正常用于验证。识别组样本量从20例阿尔茨海默病/20例认知正常增至80例阿尔茨海默病/80例认知正常时平均曲线下面积仅 marginal 增加约0.03,但最低五个曲线下面积均值从20例阿尔茨海默病/20例认知正常至30例阿尔茨海默病/30例认知正常增加约0.07、30例阿尔茨海默病/30例认知正常至40例阿尔茨海默病/40例认知正常再增0.02;识别图像分辨率在8至15毫米范围内对诊断性能影响仅 marginal,验证图像分辨率与识别图像不同时性能仍保持最优。
要点
- 识别组从20例阿尔茨海默病/20例认知正常增至80例阿尔茨海默病/80例认知正常,平均曲线下面积仅增加约0.03。
- 最低五个曲线下面积均值从20例阿尔茨海默病/20例认知正常至30例阿尔茨海默病/30例认知正常增加约0.07,30例阿尔茨海默病/30例认知正常至40例阿尔茨海默病/40例认知正常再增0.02。
- 识别图像分辨率在8至15毫米范围内对诊断性能影响仅 marginal,验证图像分辨率不同时性能仍保持最优。
核心结论
- 小样本识别组(20例阿尔茨海默病/20例认知正常图像)在病例选择有利时可能足够,但更大队列(至少30例阿尔茨海默病/30例认知正常图像)应优先采用,以克服可能的/随机的生物学差异并改善阿尔茨海默病相关模式的诊断性能。
- 阿尔茨海默病相关模式的性能在应用于分辨率不同于识别图像分辨率的验证图像时仍保持稳定。
研究设计与样本
- 从阿尔茨海默病神经影像学倡议数据库选取240例[18F]氟脱氧葡萄糖正电子发射断层扫描图像(120例阿尔茨海默病/120例认知正常)。
- 使用200例图像(100例阿尔茨海默病/100例认知正常)通过缩放子分布模型/主成分分析识别不同版本的阿尔茨海默病相关模式。
- 随机选取五个识别组各25次,识别组图像数量不同(20例阿尔茨海默病/20例认知正常、30例阿尔茨海默病/30例认知正常、40例阿尔茨海默病/40例认知正常、60例阿尔茨海默病/60例认知正常、80例阿尔茨海默病/80例认知正常)且图像分辨率不同(6、8、10、12、15和20毫米)。
- 共识别750个阿尔茨海默病相关模式,并在其余20例阿尔茨海默病/20例认知正常上以六种不同图像分辨率通过曲线下面积值进行验证。
主要发现
- 识别组样本量增加时,阿尔茨海默病相关模式区分阿尔茨海默病患者与认知正常者的平均曲线下面积仅 marginal 增加,从20例阿尔茨海默病/20例认知正常至80例阿尔茨海默病/80例认知正常曲线下面积增加约0.03。
- 最低五个曲线下面积均值随参与者数量增加而增加,从20例阿尔茨海默病/20例认知正常至30例阿尔茨海默病/30例认知正常增加约0.07,从30例阿尔茨海默病/30例认知正常至40例阿尔茨海默病/40例认知正常再增加0.02。
- 识别图像分辨率在8至15毫米范围内对阿尔茨海默病相关模式诊断性能影响仅 marginal。
- 阿尔茨海默病相关模式应用于分辨率不同于识别图像分辨率的验证图像时性能仍保持最优。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alzheimer's disease-related pattern (ADRP) is a metabolic brain biomarker of Alzheimer's disease (AD). While ADRP is being introduced into research, the effect of the size of the identification cohort and the effect of the resolution of identification and validation images on ADRP's performance need to be clarified. METHODS: 240 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography images [120 AD/120 cognitive normals (CN)] were selected from the Alzheimer's disease neuroimaging initiative database. A total of 200 images (100 AD/100 CN) were used to identify different versions of ADRP using a scaled subprofile model/principal component analysis. For this purpose, five identification groups were randomly selected 25 times. The identification groups differed in the number of images (20 AD/20 CN, 30 AD/30 CN, 40 AD/40 CN, 60 AD/60 CN, and 80 AD/80 CN) and image resolutions (6, 8, 10, 12, 15 and 20 mm). A total of 750 ADRPs were identified and validated through the area under the curve (AUC) values on the remaining 20 AD/20 CN with six different image resolutions. RESULTS: ADRP's performance for the differentiation between AD patients and CN demonstrated only a marginal average AUC increase, when the number of subjects in the identification group increases (AUC increase for about 0.03 from 20 AD/20 CN to 80 AD/80 CN). However, the average of the lowest five AUC values increased with the increasing number of participants (AUC increase for about 0.07 from 20 AD/20 CN to 30 AD/30 CN and for an additional 0.02 from 30 AD/30 CN to 40 AD/40 CN). The resolution of the identification images affects ADRP's diagnostic performance only marginally in the range from 8 to 15 mm. ADRP's performance stayed optimal even when applied to validation images of resolution differing from the identification images. CONCLUSIONS: While small (20 AD/20 CN images) identification cohorts may be adequate in a favorable selection of cases, larger cohorts (at least 30 AD/30 CN images) shall be preferred to overcome possible/random biological differences and improve ADRP's diagnostic performance. ADRP's performance stays stable even when applied to the validation images with a resolution different than the resolution of the identification ones.
引用
- Štokelj E, Tomše P, Tomanič T, et al. Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer's disease-related pattern. EJNMMI Res. 2023. PMID: 37222957. doi:10.1186/s13550-023-01001-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。